Gilead’s New Hepatitis C Combo May Be Approved ‘Very Soon’: RBC
Alert: HALISTER Source: BFW (Bloomberg First Word)
Tickers GILD US (Gilead Sciences Inc)
People Michael J Yee (RBC Capital Markets)
Topics Viral Hepatitis
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283